6 years ago

Inotec AMD Secures £7 Million to Revolutionize Chronic Wound Treatment

  • Cambridge-based medtech startup Inotec AMD has raised £7 million in funding to expand its global reach in treating chronic wounds

  • The company's innovative device offers a potential solution to a healthcare challenge costing billions annually

  • The funding round was led by Praetura Capital, with participation from Boundary Capital Partners LLP and existing investors.

      • ProblemHealthcare

      "Chronic wounds causing significant distress and cost to patients and families, with amputation often the only course of treatment"

      Solution

      "Developed a novel device capable of healing complex chronic wounds, revolutionizing wound care and minimising pain and suffering for millions of patients worldwide"

      Covered on